Pepsinogens in Health and Disease

References

• Spallanzani L. Experiences sur la digestion de l'homme et de différentes éspèces. Mourer, Lausanne 1785
   Google Scholar
• Schwann T. Uber das Wesen des Verdauungsproz. Müllers Arch J. Anat Physiol, 1836: 90–138
   Google Scholar
• Northrop J. H. Crystalline pepsin. I. Isolation and tests of purity. II. General properties and experimental methods. J Gen Physiol 1930; 13: 739–80
   PubMedGoogle Scholar
• Langley J. N. On the histology of the mammalial gastric glands and the relation of pepsin to the granules of the chief-cells. J Physiol. 1882; 3: 246–68
   PubMedGoogle Scholar
• Herriott R. M. Isolation, crystallization, and properties of swine pepsinogen. J Gen Physiol 1938; 21: 501–40
   PubMedGoogle Scholar
• Howes E. L., Flood CA, Mullins C. R. The influence of pepsin and hydrochloric acid on the healing of gastric defects. Surg Gynecol Obstet 1936; 62: 149–53
   Google Scholar
• Schiffrin M. J., Warren A. A. Some factors concerned in the production of experimental ulceration of the gastrointestinal tract in cats. Am J Dig Dis. 1942; 9: 205–8
   Google Scholar
• Taylor W. H. Studies on gastric proteolysis. III. The secretion of different pepsins by fundic and pyloric glands of the stomach. Biochem J 1959; 71: 384–8
   PubMedGoogle Scholar
• Taylor W. H. Gastric proteolysis in disease. IV. Proteinase activity of extracts of human gastric adenocarcinomata. J Clin Pathol 1960; 13: 52–349
   Google Scholar
• Taylor W. H. The pepsins of patients with peptic ulcer. Nature 1970; 227: 76–7
   PubMed Web of Science ®Google Scholar
• Taylor W. H. Electrophoretic characterization of the pepsins: pathophysiological and clinical considerations. Gastric secretion: biochemical and clinical features, M. Plebani, F. Di Mario. Piccin, Padova 1992; 23–41
   Google Scholar
• Samloff I. M. Pepsinogens and peptic ulcer. New trends in ulcer disease, Mario F. Di, G. Battaglia, F. Vianello. Piccin, Padova 1988; 17–20
   Google Scholar
• Samloff I. M. Peptic ulcer: the many proteinases of aggression. Gastroenterology 1989; 96: 586–95
   PubMed Web of Science ®Google Scholar
• Nomenclature Committee of the International Union of Biochemistry. Enzyme nomenclature. Academic Press, New York 1984
   Google Scholar
• Fruton J. S. Pepsin. The enzymes, P. D. Boyer. Academic Press, New York 1971; 119–64
   Google Scholar
• Fruton J. S. Aspartic proteinases. New comprehensive biochemistry, A. Neuberger, K. Brocklehurst. Elsevier, Amsterdam 1987; 1–37
   Google Scholar
• Polgar L. Mechanisms of protease action. CRC Press, Boca Raton 1989; 157–82
   Google Scholar
• Samloff I. M., Foltmann B. Discussion of pepsinogen classification, nomenclature and genetics of electrophoretic variants. Pepsinogens in man: clinical and genetic advances, J. Kreuning, I. M. Samloff, J. Rotter, et al. Alan R. Liss, New York 1985; 31–40
   Google Scholar
• Samloff I. M. Slow moving protease and the seven pepsinogens. Electrophoretic demonstration of the existence of eight proteolytic fractions in human gastric mucosa. Gastroenterology 1969; 57: 659–69
   PubMed Web of Science ®Google Scholar
• Samloff I. M. Pepsinogens, pepsins, and pepsin inhibitors. Gastroenterology 1971; 60: 586–604
   PubMed Web of Science ®Google Scholar
• Samloff I. M., Townes P. L. Pepsinogens: genetic polymorphism in man. Science 1970; 168: 144–5
   PubMed Web of Science ®Google Scholar
• Defize J., Pals G., Pronk J. C., et al. Purification of the pepsinogen A isozymogens by means of high resolution ion-exchange chromatography. Evidence for posttranslational modifications. Scand J Clin Lab Invest 1985; 45: 649–55
   PubMed Web of Science ®Google Scholar
• Foltmann B. Gastric proteinases. Structure, function, evolution and mechanism of action. Essays Biochem 1981; 17: 53–84
   Google Scholar
• Foltmann B. A review on prorennin and rennin. CR Trav Lab Carlsberg 1966; 35: 143–231
   PubMedGoogle Scholar
• Keilova H., Tomasek V. Effect of pepsin inhibitor from. Aspartic lumbricoides on Cathepsin D and E. Biochim Biophys Acta. 1972; 284: 461–4
   PubMedGoogle Scholar
• Tarasova N. I., Szecsi PB, Foltmann B. An aspartic proteinase from human erythrocytes is immunochemically indistinguishable from a non-pepsin, electrophoretically slow-moving proteinase from gastric mucosa. Biochim Biophys Acta 1986; 880: 96–110
   PubMedGoogle Scholar
• Samloff I. M., Taggart R. T., Shiraishi T., et al. Slow-moving proteinase. Isolation, characterization and immunohistochemical localization in gastric mucosa. Gastroenterology 1987; 93: 77–84
   PubMed Web of Science ®Google Scholar
• Jupp R. A., Richards A. D., Kay J., et al. Identification of the aspartic proteinases from human erythrocyte membranes and gastric mucosa (slow-moving proteinase) as catalytically equivalent to cathepsin E. Biochem J 1988; 254: 895–8
   PubMedGoogle Scholar
• Foltmann B., Axelsen N. H. Gastric proteinases and their zymogens. Phylogenetic and developmental aspects. FEBS Proc 1980; 60: 271–80
   Google Scholar
• Zelle B., Geurts, van Kesse J A, De Wit J., et al. Assignment of human pepsinogen A locus to the q 12-pter region of chromosome 11. Hum Genet 1985; 70: 337–40
   PubMedGoogle Scholar
• Taggart R. T., Mohandas T. K., Shows T. B., et al. Variable numbers of pepsinogen genes are located in the centromeric region of human chromosome 11 and determine the high-frequency electrophoretic polymorphism. Proc Natl Acad Sci USA 1985; 82: 6240–4
   PubMed Web of Science ®Google Scholar
• Bebelman J. P., Evers MPJ, Zelle B., et al. Family and population studies on the human pepsinogen A multigene family. Hum Genet 1989; 82: 142–6
   PubMedGoogle Scholar
• Frants R. R., Pronk J. C., Pals G., et al. Genetics of urinary pepsinogen: a new hypothesis. Hum Genet 1984; 65: 385–90
   PubMed Web of Science ®Google Scholar
• Evers MPJ, Zelle B., Bebelman J. P., et al. Nucleotide sequence comparison of five human pepsinogen A (PGA genes): evolution of the PGA multigene family. Genomics. 1989; 4: 487–9
   Google Scholar
• Taggart R. T., Samloff I. M. Immunochemical, electrophoretic and genetic heterogeneity of pepsinogen I. Characterization with monoclonal antibodies. Gastroenterology 1987; 92: 143–50
   PubMedGoogle Scholar
• Korsnes L., Gedde-Dahl T, Jr. Genetics of pepsinogen I. Ann Hum Genet 1980; 43: 199–212
   PubMed Web of Science ®Google Scholar
• Taggart R. T., Samloff I. M., Raffel L. J., et al. Relationships between the human pepsinogen DNA and protein polymorphism. Am J Hum Genet 1986; 38: 848–54
   PubMedGoogle Scholar
• Rotter J. I., Petersen G., Samloff I. M., et al. Genetic heterogeneity of hyperpepsinogenemic I and normopepsinogemic duodenal ulcer disease. Ann Int Med 1979; 91: 372–7
   PubMed Web of Science ®Google Scholar
• McConnell R. B., Linaker BD, George J. Genetic markers and severity of duodenal ulcer. Pepsinogens in man: clinical and genetic advances, J. Kreuning, I. M. Samloff, J. Rotter, A. W. Griksson. Alan R. Liss, New York 1985; 315–21
   Google Scholar
• Aird I., Bental H. H., Mehigaro J. A., et al. The blood groups in relation to peptic ulceration and carcinoma of the colon, rectum, breast and bronchus. Br Med J 1954; 315–21
   PubMedGoogle Scholar
• Clarke C. A., Edwards J. W., Haddock DRW, et al. ABO blood groups and secretor character in duodenal ulcer. Br Med J. 1956; 2: 725–31
   PubMed Web of Science ®Google Scholar
• McConnell R. B. Gastric and duodenal ulcer. The genetics of the gastrointestinal disorders. Oxford University Press, London 1966; 76–101
   Google Scholar
• Rotter J. I., Sones J. Q., Samloff I. M., et al. Duodenal ulcer disease associated with elevated serum pepsinogen. I. An inherited autosomal dominant disorder. N Engl J Med 1979; 300: 63–6
   PubMed Web of Science ®Google Scholar
• Muto N., Tani S. Genetic variation of pepsinogen I in the rat. Biochem Genet 1982; 20: 1189–93
   PubMedGoogle Scholar
• Lai K-H, Wyckoff B., Samloff I. M. Aspartic proteinases in gastric mucosa of the rat. Absence of pepsinogen I, genetic polymorphism of pepsinogen II, and presence of slow-moving proteinase. Gastroenterology 1988; 95: 295–301
   PubMedGoogle Scholar
• Pals G., Azuma T., Mohandas T. K., et al. Human pepsinogen C gene (progastricsin) polymorphism: evidence for a single locus located at 6 pt 21.1. pter. Genomics. 1989; 4: 137–48
   PubMed Web of Science ®Google Scholar
• Foltmann B., Pedersen V. B. Comparison of the primary structures of acid proteinases and of their zymogens. Adv Exp Med Biol 1977; 95: 3–22
   PubMedGoogle Scholar
• Herriott R. M. Pepsinogen and pepsin. J Gen Physiol 1962; 45: 57–62
   PubMed Web of Science ®Google Scholar
• Basson M. D., Modlin I. M. Pepsinogen: biological and pathophysiologic significance. J Surg Res 1988; 44: 82–97
   PubMedGoogle Scholar
• Andreeva N. S., Gustchina A. E., Fedorov A. A., et al. X-ray crystallographic studies of pepsin. Adv Exp Med Biol 1977; 95: 23–31
   PubMedGoogle Scholar
• Andreeva N. S., Gustchina A. E. On the supersecondary structure of acid proteases. Biochem Biophys Res Commun 1979; 87: 32–42
   PubMedGoogle Scholar
• BlundeU TL, Jones H. B., Khan G., et al. The active site of acid proteinases. FEBS Proc 1980; 60: 281–8
   Google Scholar
• Herriott R. M. Kinetics of the formation of pepsin from swine pepsinogen and identification of an intermediate compound. J Gen Physiol 1939; 22: 65–78
   Google Scholar
• Bustin M., Conway-Jacobs A. Intramolecular activation of porcine pepsinogen. J Biol Chem 1971; 246: 615–20
   PubMedGoogle Scholar
• McPhie P. A spectrophotometric investigation of the pepsinogen-pepsin conversion. J Biol Chem 1972; 247: 4277–81
   PubMed Web of Science ®Google Scholar
• Sachdev G. P., Brownstein AD, Fruton J. S. N-methyl-2-anilinonaphthalene-6-sulfonyl peptides as fluorescent probes for pepsin-substrate interaction. J Biol Chem. 1973; 248: 6292–9
   PubMedGoogle Scholar
• Al-Janabi J., Hartsuck JA, Tang J. Kinetics and mechanism of pepsinogen activation. J Biol Chem 1972; 247: 4628–32
   PubMed Web of Science ®Google Scholar
• Dykes C. W., Kay J. Conversion of pepsinogen into pepsin is not a one-step process. Biochem J 1976; 153: 141–5
   PubMedGoogle Scholar
• Marciniszyn J, Jr, Huang J. S., Hartsuck J. A., et al. Mechanism of intramolecular activation of pepsinogen. Evidence for an intermediate δ and the involvement of the active site of pepsin in the intramolecular activation of pepsinogen. J Biol Chem 1976; 251: 7095–8
   PubMedGoogle Scholar
• Christensen K. A., Pedersen VB, Foltmann B. Identification of an enzymatically active intermediate in the activation of porcine pepsinogen. FEBS Lett 1977; 76: 214–8
   PubMed Web of Science ®Google Scholar
• Auer H. E., Glick D. M. Early events of pepsinogen activation. Biochemistry 1984; 23: 2735–7
   PubMedGoogle Scholar
• Glick D. M., Auer H. M., Rich D. H., et al. Pepsinogen activation: genesis of the binding site. Biochemistry 1986; 25: 1858–61
   PubMedGoogle Scholar
• James MNG, Sielecki A. R. Structure and refinement of penicillopepsin at 1.8A resolution. J MolBiol 1983; 163: 299–303
   Google Scholar
• Powers J. C., Harley AD, Myers D. V. Subsite specificity of porcine pepsin. Adv Exp Med Biol 1977; 95: 141–57
   PubMedGoogle Scholar
• Inouye K., Fruton J. S. Studies on the specificity of pepsin. Biochemistry 1967; 6: 1765–70
   PubMed Web of Science ®Google Scholar
• Trout G. E., Fruton J. S. The side-chain specificity of pepsin. Biochemistry 1969; 8: 4183–7
   PubMedGoogle Scholar
• Auffret C. A., Ryle A. P. The catalytic activity of pig pepsin C toward small synthetic substrates. Biochem J 1979; 179: 239–46
   PubMedGoogle Scholar
• James MNG, Hsu I-N, Delbaere LTJ. Mechanism of acid protease catalysis based on the crystal structure of penicillopepsin. Nature 1977; 267: 808–13
   PubMed Web of Science ®Google Scholar
• Umezawa H. Structures and activities of protease inhibitors of microbial origin. Methods Enzymol 1976; 45: 678–82
   PubMedGoogle Scholar
• Umezawa H. Low-molecular-weight enzyme inhibitors of microbial origin. Annu Rev Microbiol 1982; 36: 75–8
   PubMed Web of Science ®Google Scholar
• Langley J. N., Edkins J. S. Pepsinogen and pepsin. J Physiol. 1886; 7: 371–415
   PubMedGoogle Scholar
• Samloff I. M. Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology 1971; 61: 185–8
   PubMed Web of Science ®Google Scholar
• Samloff I. M., Liebman W. M. Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology 1973; 65: 36–42
   PubMed Web of Science ®Google Scholar
• Suzuki S., Furihata C., Tsuyama S., et al. Immunocytochemical localization of pepsinogen in rat stomach. Histochemistry 1983; 79: 167–76
   PubMedGoogle Scholar
• Comaggia M., Capella C., Riva C., et al. Electron immunocytochemical localization of pepsinogen I in chief cells, mucous-neck cells and transitional mucous-neck/chief cells of the human fundic mucosa. Histochemistry 1986; 85: 5–11
   PubMedGoogle Scholar
• Comaggia M., Riva C., Capella C., et al. Subcellular localization of pepsinogen II in stomach and duodenum by the immunogold technique. Gastroenterology 1987; 92: 585–93
   PubMedGoogle Scholar
• Seijffers M. J., Miller LL, Segal H. L. Pepsinogen I in semen. Chromatographic separation of pepsinogen I from human semen. Proc Soc Exp Biol Med 1965; 118: 405–9
   PubMedGoogle Scholar
• Samloff I. M., Liebman W. M. Purification and immunochemical characterization of group II pepsinogens in human seminal fluid. Clin Exp Immunol 1972; 11: 405–14
   PubMedGoogle Scholar
• Helander H. F. The normal gastric mucosa. The stomach, S. Gustavsson, D. Kumar, D. Y. Graham. Churchill Livingstone, Edinburgh 1991; 1–19
   Google Scholar
• Sano J., Miki K., Ichinose M., et al. In situ localization of pepsinogens I and II mRNA in human gastric mucosa. Acta Pathol Jpn 1989; 39: 765–71
   PubMedGoogle Scholar
• Reid W. A., Valler MJ, Kay J. The immunolocalization of Cathepsin D in normal and neoplastic human tissues. J Clin Pathol 1986; 39: 1323–30
   PubMed Web of Science ®Google Scholar
• Basso D., Battistel M., Mantovani G., et al. Cathepsin D in biopsies from gastroduodenal mucosa: any role in peptic ulcer. Digestion 1991; 49(Suppl. 1)27
   Google Scholar
• Gilbert A. J., Hersey S. J. Exocytosis in isolated gastric glands induced by secretagogues and hyperosmolarity. Cell Tissue Res 1982; 227: 435–42
   Google Scholar
• Hirschowitz B. I. Secretion of pepsinogens. Handbook of Physiology: alimentary canal, C. F. Code. American Physiological Society, Washington, DC 1967; 889–918
   Google Scholar
• Pagano R., Pilotto A., Braghetto D., et al. Control of peptic secretion. Peptic secretion, Mario F. Di, F. Vianello, M. Plebani. Piccin, Padova 1985; 21–9
   Google Scholar
• Del Tacca M., Blandizzi R, Bemardini M. L. Regulation of pepsinogen secretion. Gastric peptic secretion, R. Cheli, A. Perasso, G. Testino. Raven Press, New York 1990; 21–9
   Google Scholar
• Hersey S. J. Pepsinogen secretion. Physiology of the gastrointestinal tract, L. R. Johnson. Raven Press, New York 1937; 947–57
   Google Scholar
• Hengels K. J. Cellular mechanisms of pepsinogen synthesis. Gastric secretion, M. Plebani, F. Di Mario. Piccin, Padova 1992; 15–22
   Google Scholar
• Muller-Lissner S. A., Szelenyi I., Engler H., et al. Pirenzepine inhibits acid and pepsinogen secretion by the isolated perfused mouse stomach. Scand J Gastroenterol 1982; 72: 101–3
   Google Scholar
• Hirschowitz B. I., Fong J, Molina E. Effects of pirenzepine and atropine on vagal and cholinergic gastric secretions and gastrin release and on heart rate in the dog. J Pharmacol Exp Ther 1983; 225: 263–8
   PubMed Web of Science ®Google Scholar
• Koelz H. R., Hersey S. J., Sachs G., et al. Pepsinogen release from isolated gastric glands. Am J Physiol 1982; 243: G218–25
   Google Scholar
• Hersey S. J., Miller M., May D., et al. Lack of interaction between acid and pepsinogen secretion in isolated gastric glands. Am J Physiol 1983; 245: G775–9
   Google Scholar
• Simpson L., Goldenberg D, Hirschowitz B. I. Pepsinogen secretion by the frog esophagus in vitro. Am J Physiol 1980; 238: G79–G84
   Google Scholar
• Hirschowitz B. I., Hutchison G. A. Evidence for a histamine H:receptor that inhibits pepsin secretion in the dog. Am J Physiol 1977; 233: E225–8
   Google Scholar
• Sanders M. J., Amirian D. A., Ayalon A., et al. Regulation of pepsinogen release from canine chief cells in primary monolayer culture. Am J Physiol 1983; 245: 4641–6
   Google Scholar
• Kasbekar D. K., Jensen RT, Gardner J. D. Pepsinogen secretion from dispersed glands from rabbit stomach. Am J Physiol 1983; 244: G392–6
   Google Scholar
• Stening G. F., Tohnson LR, Grossman M. I. Effect of secretin on acid and pepsin secretion in cat and dog. Gastroenterology 1969; 56: 468–75
   PubMed Web of Science ®Google Scholar
• Nakajima S., Magee D. F. Influences of duodenal acidification on acid and pepsin secretion of the stomach in dogs. Am J Physiol 1970; 218: 545–9
   PubMedGoogle Scholar
• Raufman J-P, Kasbekar D. K., Jensen R. T., et al. Potentiation of pepsinogen secretion from dispersed glands from rat stomach. Am J Physiol 1983; 245: G525–30
   Google Scholar
• Sutliff V. E., Raufman J. P., Jensen R. T., et al. Actions of vasoactive intestinal peptide and secretin in chief cells prepared from guinea pig stomach. Am J Physiol 1986; 251: G96–G102
   Google Scholar
• Hersey S. J., Norris SH, Gilbert A. J. Cellular control of pepsinogen secretion. Ann Rev Physiol 1984; 46: 393–402
   PubMedGoogle Scholar
• Raufman J-P. Gastric chief cells: receptors and signal-transduction mechanisms. Gastroenterology 1992; 102: 699–710
   PubMedGoogle Scholar
• Wollin A., Soil AH, Samloff I. M. Actions of histamine, secretin and PGE2on cyclic AMP production by isolated canine fundic mucosal cells. Am J Physiol 1979; 237: E437–43
   Google Scholar
• Norris S. H., Hersey S. J. Stimulation of pepsinogen secretion in permeable isolated gastric glands. Am J Physiol 1985; 249: G408–15
   Google Scholar
• Waldum H. L., Jorde R, Gunnes P. Renal excretion of and the effect of posture on serum group I pepsinogens. Scand J Gastroenterol 1982; 17: 253–5
   PubMed Web of Science ®Google Scholar
• ten Kate R. W., Pals G., Pronk J. C., et al. The renal handling of pepsinogens A and C in man. Clin Sci 1988; 75: 649–54
   Google Scholar
• ten Kate R. W., Pals G., Eriksson A. W., et al. The renal metabolism of pepsinogen A and C in man. Clin Nephrol 1989; 31: 103–6
   PubMed Web of Science ®Google Scholar
• Plebani M., Tessaro P., Vianello D., et al. Methods. Peptic secretion, Mario F. Di, F. Vianello, M. Plebani. Piccin, Padova 1985; 43–54
   Google Scholar
• Anson M. L., Mirsky A. The estimation of pepsin with hemoglobin. J Gen Physiol 1932; 16: 59–63
   PubMedGoogle Scholar
• Mirsky I. A., Futterman P, Kaplan S. Blood plasma pepsinogen. II. The activity of the plasma from “normal” subjects, patients with ulcer and patients with pernicious anemia. J Lab Clin Med 1952; 40: 188–99
   PubMed Web of Science ®Google Scholar
• Hirschowitz B. I. Pepsinogen in the blood. J Lab Clin Med 1955; 46: 568–79
   PubMed Web of Science ®Google Scholar
• Uete T., Wasa M, Shimigami A. A simplified method for the determination of pepsinogen in blood and urine. Clin Chem. 1969; J 5: 42–7
   Google Scholar
• Lombarts AJPF, Peters H. J. Routine determination of serum pepsinogens. Clin Chim Acta 1972; 36: 195–200
   PubMedGoogle Scholar
• Saez-Alquezar A., Marchese M. A., Bezerra TVS, et al. Serum pepsinogen: correlation of techniques and analysis of levels found in different diseases of the stomach and duodenum. Clin Chim Acta 1978; 90: 163–9
   PubMedGoogle Scholar
• Plebani M., Di Mario F., Vianello F., et al. Pepsinogen group I radioimmunoassay and total serum pepsinogen colorimetric determination: a comparative study in normal subjects and in peptic ulcer patients. Clin Biochem 1983; 16: 20–2
   PubMedGoogle Scholar
• Jones W. O. A single semiautomated method for plasma pepsinogen determination. Anal Biochem 1979; 99: 321–3
   PubMedGoogle Scholar
• Miki K., Ichinose M., Furihata C., et al. Potential peptic activity of pepsinogen of human gastro duodenal mucosa determined by fluorescent microassay method using succinyl albumin. Clin Chim Acta 1982; 121: 337–44
   PubMedGoogle Scholar
• Trevor-Ford F., Hermon Taylor J, Grant DAW. A sensitive fluorometric assay for the simultaneous estimation of pepsin and pepsinogen in gastric mucosa. Clin Chim Acta 1982; 126: 17–23
   PubMedGoogle Scholar
• Rick W., Fritsch W. P. Pepsin (pepsin, gastricsin, pepsinogen, uropepsinogen). Methods ofenzymic analysis, H. U. Bergmeyer. Academic Press, New York 1974; 1047–57
   Google Scholar
• Samloff I. M., Liebman W. M. Radioimmunoassay of group I pepsinogens in serum. Gastroenterology 1974; 66: 494–502
   PubMed Web of Science ®Google Scholar
• Axelsson C. R., Nielsen MD, Kappelgaard A. M. Solid-phase double-antibody radioimmunoassay of pepsinogen I in serum. Clin Chim Acta 1982; 121: 309–19
   PubMed Web of Science ®Google Scholar
• Biemond I., Jansen JBMJ, Crobach LFSJ, et al. Radioimmunoassay of human pepsinogen A and pepsinogen C. J Clin Chem Clin Biochem 1989; 27: 19–25
   PubMedGoogle Scholar
• Hengels K. J., Strohmeyer G. Pepsinogens A and C: purification from human gastric mucosa and determination in serum by optimized radioimmunoassays. Z Gastroenterol 1989; 27: 406–11
   PubMedGoogle Scholar
• Biemond I., Pals G., Giliams J. P., et al. Enzyme linked immunosorbent assay of pepsinogen I. Progress in clinical and biological research, J. Kreuning, I. M. Samloff, J. I. Rotter, A. W. Eriksson. Alan R. Liss, New York 1985; 55–65
   Google Scholar
• Huang S. C., Miki K., Hirano H., et al. Enzyme-linked immunosorbent assay of serum pepsinogen I. Clin Chim Acta 1987; 162: 85–96
   PubMedGoogle Scholar
• Ichinose M., Miki K., Furihata C., et al. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta 1982; 126: 183–91
   PubMed Web of Science ®Google Scholar
• Axelsson C. K. Determination of pepsinogen I in serum by radioimmunoassay. Progress in clinical and biological research, J. Kreuning, I. M. Samloff, J. I. Rotter, A. W. Eriksson. Alan R. Liss, New York 1985; 43–53
   Google Scholar
• Huang S. C., Miki K., Furihata C., et al. Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies–with data on peptic ulcer and gastric cancer. Clin Chim Acta 1988; 175: 37–50
   PubMed Web of Science ®Google Scholar
• Samloff I. M. Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 1982; 82: 26–33
   PubMed Web of Science ®Google Scholar
• Ichinose M., Miki K., Furihata C., et al. Radioimmunoassay of group II pepsinogen in human serum. Clin Chim Acta 1982; 122: 61–9
   PubMedGoogle Scholar
• Plebani M., Masiero M., Di Mario F., et al. Radioimmunoassay for pepsinogen C. Clin Chem 1990; 36: 1690
   PubMedGoogle Scholar
• Matzku S., Zoller M, Rapp W. Radioimmunological quantitation of human group II pepsinogens. Digestion 1978; 18: 16–26
   PubMed Web of Science ®Google Scholar
• Matsusako K., Itoh M., Yokochi K., et al. An enzyme immunoassay for pepsinogen II (PGII): chronological changes in serum PGII concentrations. Clin Chim Acta 1987; 239: 239–48
   Google Scholar
• Samloff I. M., Townes P. L. Electrophoretic heterogeneity and relationships of pepsinogens in human urine, serum, and gastric mucosa. Gastroenterology 1970; 58: 462–9
   PubMed Web of Science ®Google Scholar
• Yamaguchi T., Takahashi T., Yokota T., et al. Urinary pepsinogen I as a tumor marker of stomach cancer after total gastrectomy. Cancer 1991; 68: 906–9
   PubMed Web of Science ®Google Scholar
• Vianello F., Plebani M., Germana B., et al. Evaluation of peptic secretion. Gastric secretion, M. Plebani, F. Di Mario. Piccin, Padova 1992; 43–59
   Google Scholar
• Turner M. D. Pepsinogens and pepsin [review]. Gut. 1968; 9: 134–8
   PubMedGoogle Scholar
• Plebani M., Di Mario F., Dal Santo P. G., et al. Measurement of pepsinogen group I in endoscopic gastroduodenal biopsies. Clin Chem 1990; 36: 682–4
   PubMedGoogle Scholar
• Kiihn S. H., Bezuidenhout DDJ. Enzymatic analysis of gastric microbiopsy specimens. An aid in the differential diagnosis between peptic ulcer and gastric carcinoma. Cancer 1983; 51: 1653–5
   PubMedGoogle Scholar
• Stemmermann G. N., Samloff IM, Hayashi T. Pepsinogens I and II in carcinoma of the stomach: an immunohistochemical study. Appl Pathol. 1985; 3: 159–63
   PubMedGoogle Scholar
• Muto N., Yamamoto M., Tani S., et al. Characteristic distribution of cathepsin E which immunologically cross-reacts with the 86-kDa acid proteinase from rat gastric mucosa. J Biochem 1988; 103: 629–32
   PubMedGoogle Scholar
• Shiraishi T., Samloff I. M., Taggart R. T., et al. Slow-moving proteinase in gastric cancer and its relationship to pepsinogens I and II. An immunohistochemical study. Dig Dis Sci 1988; 33: 1466–72
   PubMedGoogle Scholar
• Sakai H., Saku T., Kato Y., et al. Quantitation and immunohistochemical localization of cathepsins E and D in rat tissues and blood cells. Biochim Biophys Acta 1989; 991: 367–75
   PubMedGoogle Scholar
• Perasso A., Testino G. Chief cell mass and pepsinogen I in peptic ulcer. Gastric peptic secretion, R. Cheli, A. Perasso, G. Testino. Cortina International-Raven Press, New York 1990; 101–8
   Google Scholar
• Perasso A. Testino G Pepsinogene I serique, masse cellulaire zy mogenique et masse parietale apres traitement par ranitidine dans l'ulcere duodenal. Ann Gastroenterol Hepatol 1991; 27: 154–7
   Google Scholar
• Testino G., Perasso A. Masse cellulaire parietale, masse cellulaire zymogenique, secretion acide et pepsinogene I (PGI) de 1'ulcere gastrique. Gastroenterol Clin Biol 1992; 16: A157
   Google Scholar
• Pilotto A., Tessaro P, Plebani M. Secretion. Peptic secretion, Mario F. Di, F. Vianello, M. Plebani. Piccin, Padova 1985; 13–9
   Google Scholar
• Samloff I. M., Secrist DM, Passaro E, Jr. A study of the relationship between serum group I pepsinogen levels and gastric acid secretion. Gastroenterology 1975; 69: 1196–200
   PubMed Web of Science ®Google Scholar
• Samloff I. M., Varis K., Ihamaki T., et al. Relationships among serum pepsinogen I, serum pepsinogen II and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 83: 204–9
   PubMed Web of Science ®Google Scholar
• Samloff I. M. Peptic activity and peptic inhibitors. Principles and practice of gastroenterology and hepatology, G. Gitnick. Elsevier, New York 1988; Pp. 154–63
   Google Scholar
• Tarquini B., Benvenuti M., Cavallini V., et al. Pepsinogen gastrin mesor ratio: a potential simple marker for.gastric secretory function%. Chronobiologia 1984; 11: 11–7
   PubMedGoogle Scholar
• Plebani M., Di Mario F., Vianello F., et al. Circadian rhythm of serum pepsinogen group I. J Lab Med. 1986; 2: 97–9
   Google Scholar
• Mastropaolo G., Kusstatscher S., Germana B. Circadian rhythm of peptic secretion: influences of endogenous and external factors. Peptic secretion, R. Cheli, A. Perasso, G. Testino. Cortina Int., Verona 1990; 47–52
   Google Scholar
• Samloff I. M., Liebman WM, Panitch N. M. Serum group I pepsinogen by radioimmunoassay in control subjects and patients with peptic ulcer. Gastroenterology 1975; 69: 83–90
   PubMed Web of Science ®Google Scholar
• Kekki M., Samloff I. M., Sipponen P., et al. Increase of serum pepsinogen I with age in females with normal gastric mucosa but not in males, possibly due to increase in acid-pepsin secreting area. Scand J Gastroenterol 1991; 26: 62–4
   Web of Science ®Google Scholar
• Whitecross D. P., Clarke AD, Piper D. W. The effect of cigarette smoking on human gastric secretion. Scand J Gastroenterol. 1974; 9: 399–403
   PubMed Web of Science ®Google Scholar
• Parente F., Lazzaroni M., Sangaletti O., et al. Cigarette smoking, gastric acid secretion, and serum pepsinogen I concentrations in duodenal ulcer patients. Gut 1985; 26: 1327–32
   PubMed Web of Science ®Google Scholar
• Malesci A., Basilico M., Bersani M., et al. Serum pepsinogen I elevation in cigarette smokers. Scand J Gastroenterol 1988; 23: 602–6
   PubMed Web of Science ®Google Scholar
• Pelissero A., Di Napoli A., Peyre S., et al. Serum group I pepsinogens level in normal adult. J Clin Gastroenterol. 1986; 8: 499
   PubMedGoogle Scholar
• Puurunen J. Effect of ethanol on peptic activity in the rat stomach. Digestion 1982; 23: 97–103
   PubMedGoogle Scholar
• Peetsalu A., Tamm A., Harkonen M., et al. The effect of vagotomy and antrectomy on serum pepsinogens I and II. Scand J Gastroenterol 1990; 25: 455–61
   PubMed Web of Science ®Google Scholar
• Magni G., Di Mario F., Rizzardo R., et al. Personality profiles of patients with duodenal ulcer. Am J Psychiatry 1986; 143: 1297–300
   PubMedGoogle Scholar
• Magni G., Di Mario F., Cortese M., et al. Relationship between psychosocial factors and serum level of pepsinogen group I and gastrinemia in the normal subject. Int J Psychophysiol. 1988; 6: 71–3
   PubMedGoogle Scholar
• Walker P., Luther J., Samloff I. M., et al. Life events stress and psychosocial factors in men with peptic ulcer disease. II. Relationships with serum pepsinogen concentrations and behavioral risk factors. Gastroenterology 1988; 94: 323–30
   PubMed Web of Science ®Google Scholar
• Feldman M., Walker P., Goldschmiedt M., et al. Role of affect and personality in gastric acid secretion and serum gastrin concentration. Comparative studies in normal men and in male duodenal ulcer patients. Gastroenterology 1992; 102: 175–80
   PubMed Web of Science ®Google Scholar
• Massarrat S. Serum pepsin activity as a parameter of gastric acid secretion. Hepato-Gastroenterol 1985; 32: 185–90
   PubMedGoogle Scholar
• Feldman M., Richardson C. T., Lam S. K., et al. Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in occidental and oriental duodenal ulcer patients. Gastroenterology 1988; 95: 630–5
   PubMed Web of Science ®Google Scholar
• Ansaldi N., Altare F., Farina L., et al. Serum pepsinogen I in children. Its correlation with gastric acid output and serum gastrin. Ital J Pediatr 1988; 14: 156–9
   Google Scholar
• Rotter J. I., Rimoin D. L. Peptic ulcer disease: a heterogeneous group of disorders. Gastroenterology 1977; 73: 604–7
   PubMed Web of Science ®Google Scholar
• Plebani M., Di Mario F., Vianello F., et al. Actual role of pepsinogen group I in the study of upper gastrointestinal diseases. Clin Biochem 1983; 16: 310–2
   PubMed Web of Science ®Google Scholar
• Rotter J. I., Petersen G. M. Heterogeneity of peptic ulcer disease. New trends in ulcer disease, Mario F. Di, G. Battaglia, F. Vianello. Piccin, Padova 1988; 21–59
   Google Scholar
• Chinn A. B. Studies on a blood serum proteolytic enzyme with particular reference to gastric secretory function. Gastroenterology 1953; 25: 14–23
   PubMedGoogle Scholar
• Spiro H. M., Ryan A. E., Jones C. M. The utility of the blood pepsin assay in clinical medicine. N Engl J Med 1955; 253: 261–6
   PubMed Web of Science ®Google Scholar
• Hoar C. S., Browning J. R. Plasma pepsinogen in peptic-ulcer disease and other gastric disorders. A clinical and laboratory investigation. N Engl J Med 1956; 255: 153–8
   PubMedGoogle Scholar
• Edwards K., Jepson RP, Wood K. F. Value of plasma pepsinogen estimation. Br Med J. 1960; 1: 30–2
   PubMed Web of Science ®Google Scholar
• Lee T. Studies of plasma pepsinogen. J Formosan Med Assoc 1960; 59: 624–58
   Google Scholar
• Anscombe A. R. Plasma pepsinogen: normal and abnormal secretion. Ann R Coll Surg Engl 1964; 35: 34–49
   PubMedGoogle Scholar
• Naganna B., Balasundaram D, Venkaiah K. R. Plasma pepsinogen in health and gastroduodenal disorders. J Indian Med Assoc 1972; 58: 6–9
   PubMedGoogle Scholar
• Modlin I. M., Basson M. D. Blood pepsinogen: clinical and research significance. Clinical investigation of gastric function, C. Scarpignato, G. Bianchi Porro. Karger, Basel 1990; 157–71
   Google Scholar
• Niederman J. C., Spiro HM, Sheldon W. H. Blood pepsin as a marker of susceptibility to duodenal ulcer disease. Arch Environ Health 1964; 8: 540–6
   PubMed Web of Science ®Google Scholar
• Ippoliti A., Walsh J. Newer concepts in the pathogenesis of peptic ulcer disease. Surg Clin North Am 1976; 56: 1479–90
   PubMedGoogle Scholar
• Rhodes J. Etiology of gastric ulcer. Gastroenterology 1972; 63: 171–82
   PubMed Web of Science ®Google Scholar
• Soil A. H. Pathogenesis of peptic ulcer and implications for therapy. A'. Engl J Med 1990; 322: 909–16
   PubMedGoogle Scholar
• Vianello F., Plebani M., Piccoli A., et al. Role of serum pepsinogen in detecting ulcer disease. Clin Chim Acta 1988; 172: 335
   PubMed Web of Science ®Google Scholar
• Samloff I. M., Stemmermann G. N., Heiibrun K., et al. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology 1986; 90: 570–45
   PubMed Web of Science ®Google Scholar
• Chuong JJH, Fisher R. L., Chuong RLB, et al. Duodenal ulcer. Incidence, risk factors, and predictive value of plasma pepsinogen. Dig Dis Sci 1986; 31: 1178–84
   PubMed Web of Science ®Google Scholar
• Habibullah C. M., Mujahid Ali M., Ishaq M., et al. Study of duodenal ulcer disease in 100 families using total serum pepsinogen as a genetic marker. Gut 1984; 25: 1380–3
   PubMedGoogle Scholar
• Vianello F., Di Mario F., Cedaro P., et al. Subclinical markers in a family with higher prevalence of peptic ulcer. Ital J Gastroenterol 1985; 17: 290–2
   Google Scholar
• Taylor I. L., Calam J., Rotter J. I., et al. Family studies of hypergastrinemic, hyperpepsinogenemic I duodenal ulcer. Ann Int Med 1981; 95: 421–5
   PubMed Web of Science ®Google Scholar
• Lamers CBHW, Jarisen JBMJ, Rotter J. I., et al. Serum pepsinogen I in hereditary hypergastrinemic peptic ulcer syndromes. Pepsinogens in man: clinical and genetic advances, J. Kreuning, I. M. Samloff, J. Rotter, A. W. Eriksson. Alan R. Liss, New York 1985; 273–81
   Google Scholar
• Sumii K., Uemera N, Inbe A. Familial aggregation of duodenal ulcer and an autosomal dominant inheritance of hyperpepsinogenemia I. Hiroshima J Med Sci 1986; 35: 171–5
   PubMedGoogle Scholar
• Mourant A. E., Kopec A. C. Domaniewska-Sobczak K. Blood groups and diseases. Oxford University Press, Oxford 1978
   Google Scholar
• Sumii K., Inbe A., Uemura N. Multiplicative effect of hyperpepsinogenemia I and non-secretor status on the risk of duodenal ulcer in siblings. Gastroenterol Jpn 1990; 25: 157–61
   PubMedGoogle Scholar
• Rotter J. I. Peptic ulcer disease-more than one gene, more than one disease. Progress in medical genetics, A. G. Steinberg, A. G. Beam, A. G. Motulsky, B. Childs. WB Saunders, Philadelphia 1980; 1–58
   Google Scholar
• Rotter J. I. Peptic ulcer. The principles and practice of medical genetics, AEH Emery, D. L. Rimoin. Churchill Livingstone, Edinburgh 1983; 863–78
   Google Scholar
• Venturi C., Bortolami M., Di Mario F., et al. Serum pepsinogen I levels and HLA-B22: a genetic association in a subgroup of duodenal ulcer patients. Hal J Gastroenterol 1986; 18: 77–8
   Google Scholar
• Petersen G. M., Lam S. K., Samloff I. M., et al. Genetic factors predict duodenal ulcer healing (Abstract). Gastroenterology 1985; 88: 1538
   Google Scholar
• Battaglia G., Farini R., Di Mario F., et al. Recurrence of duodenal ulcer under continuous antisecretory treatment: an approach to the detection of predictive markers. Am J Gastroenterol 1984; 79: 831–4
   PubMed Web of Science ®Google Scholar
• Samloff I. M., Secris DM, Passaro E, Jr. Serum group I pepsinogen levels and their relation to gastric acid secretion in patients with and without recurrent ulcer. Gastroenterology 1976; 70: 309–13
   PubMed Web of Science ®Google Scholar
• Sumii K., Inbe A., Uemura N., et al. Increased serum pepsinogen I and recurrence of duodenal ulcer. Stand J Gastroenterol 1989; 24: 1200–4
   PubMed Web of Science ®Google Scholar
• Tanaka Y., Mine K., Nakai Y., et al. Serum pepsinogen I concentrations in peptic ulcer patients in relation to ulcer location and stage. Gut 1991; 36: 424–30
   Google Scholar
• Hui W-M, Ho J., Lam S-K. Pathogenetic role of. Helicobacter pylori in duodenal ulcer disease. Dig Dis Sci. 1991; 36: 424–30
   PubMedGoogle Scholar
• Spiro H. M., Schwartz RDL. Superficial gastritis: a cause of temporary achlorhydria and hyperpepsinogenemia. N Engl J Med 1958; 259: 682–84
   PubMed Web of Science ®Google Scholar
• Segal H. L., Samloff I. M. Tubeless gastric analysis techniques in diagnosis of chronic gastritis. JAMA 1966; 197: 717–8
   PubMedGoogle Scholar
• Samloff I. M., Varis K., Ihamaki T., et al. Serum pepsinogens I and II and gastric acid output: effect of gastritis. Pepsinogens in man: clinical and genetic advances, J. Kreuning, I. M. Samloff, J. Rotter, A. W. Eriksson. Alan R. Liss, New York 1985; 139–46
   Google Scholar
• Bock OAA, Arapakis G., Witt L. I., et al. The serum pepsinogen level with special reference to the histology of the gastric mucosa. Gut 1963; 57: 159–62
   Google Scholar
• Varis K., Samloff I. M., Imamaki T., et al. An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia. Digree's Sc; 1979; 24: 91–187
   Google Scholar
• Sipponen P., Samloff I. M., Saukkonen M., et al. Serum pepsinogens I and II and gastric mucosal histology after partial gastrectomy. Gut 1987; 26: 1179–82
   Google Scholar
• Miki K., Ichinose M., Shimizu A., et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987; 22: 133–41
   PubMedGoogle Scholar
• Hirayama T. Epidemiology of stomach cancer. Gann Monogr Cancer Res 1971; 11: 3–91
   Google Scholar
• Biasco G., Paganelli G. M., Azzaroni D., et al. Early gastric cancer in Italy. Clinical and pathological observations on 80 cases. Dig Dis Sci 1987; 32: 113–20
   PubMedGoogle Scholar
• Sipponen P., Kekki M., Haapakoski J., et al. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985; 35: 173–7
   PubMed Web of Science ®Google Scholar
• Stemmermann G. N., Ishidate T, Samloff I. M. Intestinal metaplasia of the stomach in Hawaii and Japan: a study of its relation to serum pepsinogen I, gastrin and parietal cell antibodies. Am J Dig Dis 1978; 23: 815–20
   PubMedGoogle Scholar
• Nomura AMY, Stemmermann GN, Samloff I. M. Serum pepsinogen I as a predictor of stomach cancer. Ann Int Med 1980; 93: 531–40
   Google Scholar
• Stemmermann G. N., Samloff I. M., Heilbrun L. K., et al. Serum pepsinogens I and II and stomach cancer. Clin Chim Acta 1987; 163: 191–8
   PubMed Web of Science ®Google Scholar
• Miki K., Ichinose M., Kawamura N., et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989; 80: 111–4
   PubMedGoogle Scholar
• Plebani M., Burlina A. Biochemical markers of atrophic gastritis and gastric cancer. Chronic atrophic gastritis, Mario F. Di, F. Farinati, G. Leandro. Piccin, Padova 1991; 61–8
   Google Scholar
• Westerveld B. D., Pals G., Lamers CBHW, et al. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer 1987; 59: 952–8
   PubMed Web of Science ®Google Scholar
• Farinati F., Di Mario F., Plebani M., et al. Pepsinogen A/Pepsinogen C or Pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer%. Ital J Gastroenterol 1991; 223: 194–6
   Google Scholar
• Heptner G., Domschke S., Domschke W. Comparison of CA 72–4 with CA 19–9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies. Stand J Gastroenterol 1989; 24: 745–50
   PubMed Web of Science ®Google Scholar
• Plebani M., Burlina A. Aspartic proteinases as tumour markers. Updating on tumor markers in tissue and in biological fluids. Basic aspects and clinical applications, A. Ballesta, G. C. Torre, E. Bombardieri, M. Gion, R. Molina. Minerva Medica, Torino 1993; 273–82
   Google Scholar
• Kekki M., Samloff I. M., Varis K., et al. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Stand J Gastroenterol 1991; 26: 109–16
   PubMed Web of Science ®Google Scholar
• Varis K., Kekki M., Harkonen M., et al. Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Stand J Gastroenterol 1991; 26: 117–23
   Web of Science ®Google Scholar
• Hirsch-Marie H., Loisillier F., Touboul J. P., et al. Immunochemical study and cellular localization of human pepsinogens during ontogenesis and in gastric cancers. Lab Invest. 1976; 6: 623–32
   Google Scholar
• Reid W. A., Thompson WD, Kay J. Pepsinogen in gastric carcinoma cells. J Clin Pathol 1983; 36: 137–9
   PubMedGoogle Scholar
• Reid W. A., Kay J. Gastrics in the cells of gastric carcinomas. Dis Markers. 1983; 1: 263–9
   Google Scholar
• Meuwissen SGM, Mullink H., Bosma A., et al. Immunocytochemical localization of pepsinogen A and C in the human stomach. Pepsinogens in man: clinical and genetic advances, J. Kreuning, I. M. Samloff, J. I. Rotter, H. W. Eriksson. Alan R. Liss, New York 1984; 185–96
   Google Scholar
• Weinstein V. M., Lechago J., Samloff I. M., et al. Pepsinogens in human gastric cardiac and esophageal glands. Clin Res 1977; 25: 690–3
   Google Scholar
• Wamer T. F., Donnelly W. J., Hafez G. R., et al. Immunocytochemical evidence for gastric proteases in adenocarcinoma of the stomach. Cancer 1986; 58: 1328–32
   PubMedGoogle Scholar
• Saku T., Sakai H., Tsuda N., et al. Cathepsins D and E in normal, metaplastic, dysplastic, and carcinomatous gastric tissue: an immunohistochemical study. Gut 1990; 31: 1250–5
   PubMedGoogle Scholar
• Fiocca R., Villani L., Tenti P., et al. Characterization of four main cell types in gastric cancer; foveolar, mucopeptic, intestinal columnar and goblet cells. An histopathologic, histochemical and ultrastructural study of “early” and “advanced” tumours. Pathol Res Pract 1987; 182: 308–25
   PubMed Web of Science ®Google Scholar
• Fiocca R., Comaggia M., Villani L., et al. Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases. Cancer 1988; 61: 956–62
   PubMedGoogle Scholar
• Goodwin C. S., Armstrong JA, Chilvers T. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov., Helicobacter mustelae comb, nov., respectively. Int J Syst Bacteriol. 1989; 39: 397–405
   Google Scholar
• Goodwin C. S., McConnell W, McCulloch R. K., et al. Cellular fatty acid composition of Campylobacter pylori from primates and ferrets compared with those of other Campylobacters. J Clin Microbiol 1989; 27: 43–938
   Google Scholar
• Warren J. R., Marshall B. J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; I: 5–1273
   Google Scholar
• Marshall B. J., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; I: 5–1311
   Google Scholar
• Buck G. E., Gourley W. K., Lee W. K., et al. Relation of. Campylobacter pyloridis to gastritis and peptic ulcer. J Infect Dis. 1986; 153: 664–9
   PubMed Web of Science ®Google Scholar
• Dooley C. P., Cohen H., Fitzgibbons P. L., et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562–6
   PubMed Web of Science ®Google Scholar
• Malfertheiner P., Pieramico O. Helicobacter pylori. The stomach, S. Gustavsson, D. Kumar, D. Y. Graham. Churchill Livingstone, Edinburgh 1992; 297–311
   Google Scholar
• Misiewicz JJ, Tytgat GNJ, Goodwin C. S., et al. The Sydney System: a new classification of gastritis. Working Party Reports of the 9th World Congress of Gastroenterology. Melbourne. 1990; 1–10
   Google Scholar
• Misiewicz J. J. The Sydney System: a new classification of gastritis. Introduction. J Gastroenterol Hepatol. 1991; 6: 207–8
   PubMed Web of Science ®Google Scholar
• Sipponen P., Price A., Kekki M., et al. Gastritis. The stomach, S. Gustavsson, D. Kumar, D. Y. Graham. Churchill Livingstone, Edinburgh 1992; 313–39
   Google Scholar
• Goodwin C. S., Armstrong JA, Marshall B. J. Campylobacter pyloridis. gastritis, and peptic ulceration. J Clin Pathol. 1986; 39: 353–65
   PubMed Web of Science ®Google Scholar
• Rathbone B. J., Wyatt JI, Heatley R. V. Campylobacter pyloridis - a new factor in peptic ulcer disease%. Gut 1986; 27: 635–41
   PubMed Web of Science ®Google Scholar
• Blaser M. J. Gastric. Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology 1987; 93: 371–83
   PubMed Web of Science ®Google Scholar
• Malfertheiner R. P., Stanesu A., Bode G., et al. Gastric metaplasia in duodenal mucosa-key factor for. H. pyloricolonization and duodenal ulcer pathogenesis.Helicobacter pylori, gastritis and peptic ulcer, P. Malfertheiner, H. Ditshumeit. Springer-Verlag, Berlin 1990; 292–301
   Google Scholar
• Niemela S., Kartunnen T, Lehtola J. Campylobacter-like organisms in patients with gastric ulcer. Scand J Gastroenterol 1987; 22: 487–90
   PubMed Web of Science ®Google Scholar
• Sidebottam R. L., Baron J. H. Hypothesis: Helicobacter pylori, mucosa, urease and gastric ulcer. Lancet 1990; 335: 193–5
   PubMedGoogle Scholar
• Fox J. G., Correa P., Taylor N. S., et al. Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol. 1989; 84: 775–81
   PubMed Web of Science ®Google Scholar
• Forman D., Sitas F, Newell D. G. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46: 608–11
   PubMed Web of Science ®Google Scholar
• Nomura A., Stemmermann G. N., Chyou P-H, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991; 325: 1132–6
   PubMed Web of Science ®Google Scholar
• Parsonnet J., Friedman G. D., Vandersteen D. P., et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991; 325: 1127–31
   PubMed Web of Science ®Google Scholar
• Siurala M., Sipponen P, Kekki M. Chronic gastritis: dynamic and clinical aspects. Scand J Gastroenterol 1985; 109: 69–76
   Google Scholar
• Blaser M. J. Pathogenesis of Helicobacter py/on'-induced gastroduodenal diseases. New antibacterial strategies, H. C. Neu. Churchill Livingstone, London 1990; 143–53
   Google Scholar
• Correa P., Haenszel W. Epidemiology of gastric cancer. The Hague, Epidemiology of cancer of the digestive tract, P. Correa, W. Haenszel. Martinus Nijhoff, The Netherlands 1982; 58–84
   Google Scholar
• Correa P. The gastric precancerous process. Cancer Surv. 1983; 2: 437–50
   Google Scholar
• Correa P. Is gastric carcinoma an infectious disease%. N Engl J Med 1991; 325: 1170–1
   PubMed Web of Science ®Google Scholar
• Oderda G., Vaira D., Holton J., et al. Serum pepsinogen I and IgG antibody to Campylobacter pylori in non-specific abdominal pain in childhood. Gut 1989; 30: 512–6
   Google Scholar
• Oderda G., Vaira D., Dell'Olio D., et al. Serum pepsinogen I and gastrin concentrations in children positive for. Helicobacter pylori. J Clin Pathol 1990; 43: 762–5
   PubMed Web of Science ®Google Scholar
• Karnes WE, Jr, Samloff I. M., Siurala M., et al. Positive serum antibody and negative tissue staining for. Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991; 101: 167–74
   PubMed Web of Science ®Google Scholar
• Plebani M., Di Mario F., Stanghellini V., et al. Serological tests to monitor treatment of Helicobacter pylori. Lancet 1992; 340: 51–2
   PubMedGoogle Scholar
• Chittajallu R. S., Dorrian C. A., Ardill JES, et al. Effect of. Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol. 1992; 27: 20–4
   PubMed Web of Science ®Google Scholar
• Trusdale R. A., Samloff I. M., Chamberlain C. E., et al. Serum pepsinogen I and II levels reflect the status of. Helicobacter pylori infection and response to treatment. Gastroenterology 1992; 102: A180
   Google Scholar
• Vianello F., Plebani M., Di Mario F., et al. Total and group I serum pepsinogen after ranitidine and cimetidine injection. J Res Lab Med 1982; 6: 609–12
   Google Scholar
• Pkkarainen P., Vuoristo M, Tarpila S. Ulcer healing and serum pepsinogen in cimetidine and glycopyrrolate treated duodenal ulcer patients. Ann Clin Res 1981; 13: 81–4
   PubMedGoogle Scholar
• Sewing K. F., Hagle C., Ippoliti A. F., et al. Effect of 1 -month treatment with cimetidine on gastric secretion and serum gastrin and pepsinogen levels. Gastroenterology 1978; 74: 376–9
   Web of Science ®Google Scholar
• Di Mario F., Plebani M., Vianello F., et al. Serum pepsinogen in normal subjects and in peptic ulcer and its modification after ranitidine treatment. Gut 1980; 21: A930
   Google Scholar
• Plebani M., Mantovani G., Masiero M., et al. Measurement of aspartic proteinases in endoscopic gastroduodenal biopsies. Gastric secretion, M. Plebani, F. Di Mario. Piccin, Padova 1992; 61–73
   Google Scholar
• Gabryelewicz A., Laszewiez W, Sarosiek J. The influence of various secretory inhibitors on peptic activity. Scand J Gastroenterol 1980; 15: 79–85
   Google Scholar
• Cesnik R. H. Pepsinogen in gastric juice, blood and urine after proximal selective vagotomy and administration of pirenzepine or cimetidine. Advances in gastroenterology with the selective anti-muscarinic compound pirenzepine, G. Dotevall. Excerpta Medica, Amsterdam 1982; 88–95
   Google Scholar
• Vianello F., Di Mario F., Plebani M., et al. Serum pepsinogen after bolus i.v. injection of pirenzepine in healthy subjects and after oral administration in duodenal ulcer patients. J Res Lab Med 1984; 6: 567–79
   Google Scholar
• Lind T., Cederberg C., Ekenved G., et al. Effect of omeprazole–a gastric proton pump inhibitor – on pentagastrin stimulated acid secretion in man. Gut 1983; 24: 270–6
   PubMed Web of Science ®Google Scholar
• Baak L. C., Biemond I., Jansen JBMJ, et al. Repeated intravenous bolus injections of omeprazole: effects on 24-h intragastric pH, serum gastrin, and serum pepsinogen A and C. Scand J Gastroenterol 1991; 26: 737–46
   PubMed Web of Science ®Google Scholar
• Festen HPM, Tuynman HARE Defize J. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels. Dig Dis Sci 1986; 31: 561–6
   PubMed Web of Science ®Google Scholar
• Biemond I., Crobach LFST, Jansen JBMJ, et al. Effect of short-term omeprazole administration of serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion. Eur J Clin Pharmacol 1989; 37: 345–9
   PubMed Web of Science ®Google Scholar
• Jansen JBMJ, Klinkenberg-Knol E. C., Meuwissen SGM, et al. Effect of long-treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology 1990; 99: 621–8
   PubMed Web of Science ®Google Scholar
• Baak L. C., Jansen JBMJ, Biemond I., et al. Weekend treatment with 20 and 40 mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens. Gut 1991; 32: 977–82
   PubMedGoogle Scholar
• Festen HPM, Thys J. C., Lamers CBHW, et al. Effects of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology 1984; 87: 1030–34
   PubMed Web of Science ®Google Scholar
• Basson M. D., Adrian T. E., Modlin I. M. Dissociation of pepsinogen and acid secretion in guinea pig. Gastroenterology 1988; 95: 321–6
   PubMed Web of Science ®Google Scholar
• Fryklund J., Wallmark B, Larsson H. Effect of omeprazole on gastric secretion in H+K+-ATP-ase and in pepsinogen-rich fractions from rabbit gastric mucosa. Biochem Pharmacol 1984; 33: 273–80
   PubMed Web of Science ®Google Scholar
• ten Kate R. W., Tuynman HARE, Festen HPM, et al. Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man. Eur J Clin Pharmacol 1988; 32: 173–6
   Google Scholar
• Samloff I. M., Secrist DM, Passaro E. Effect of betazole on serum group I pepsinogen levels: relationship to gastric acid output in unoperate and postoperative patients. Gastroenterology 1977; 72: 845–8
   PubMed Web of Science ®Google Scholar
• Waldum H. L., Burhol P. G. The effect of secretin on serum group I pepsinogens in man. Scand J Gastroenterol 1980; 15: 273–6
   PubMed Web of Science ®Google Scholar
• Haukeland H. H., Waldum HL, Johnsen J. A. Effect of proximal gastric vagotomy on insulin induced gastric H+and pepsin secretion and serum group I pepsinogens. Scand J Gastroenterol 1982; 17: 555–9
   PubMed Web of Science ®Google Scholar
• Raufman J. P., Sutliff V. E., Kasbekar D. K., et al. Pepsinogen secretion from dispersed chief cells from guinea pig stomach. Am J Physiol 1984; 247: G95–G104
   Google Scholar
• Hersey S. J., May D., Schyberg D. Stimulation of pepsinogen release from isolated gastric glands by cholecystokininlike peptides. Am J Physiol 1983; 244: G192–97
   PubMed Web of Science ®Google Scholar
• Roberts N. B., Taylor W. H. The inactivation by carbenoxolone of individual human pepsinogens and pepsins. Clin Sci Mol Med 1973; 45: 213–24
   PubMedGoogle Scholar
• Northrop J. H., Kunitz M, Heriott R. M. Crystalline enzymes. Columbia University Press, New York 1948; 303–7
   Google Scholar
• Saemundsson J. A method for proteolytic enzyme determination. Acta Med Scand. 1951; 140(Suppl. 259)158–65
   Google Scholar
• Kowalewski K., Norvell S. T. Assay of proteolytic enzymes. Can J Biochem Physiol 1955; 33: 599–10
   PubMedGoogle Scholar
• Jackson W. T., Schlamowitz M, Shaw A. Kinetics of the pepsin-catalyzed hydrolysis of N-acetyl-L-phenylalanyl-L-diiodotyrosine. Biochemistry 1965; 4: 1537–2053
   PubMed Web of Science ®Google Scholar